Life science funding in Raleigh-Durham has cooled down in the past year

Q2 2022 was the high for life science investment in Raleigh-Durham, which was largely driven by debt/equity and late-stage funding, all quarters since have seen a decrease. Despite this cooldown, Q1 and Q2 2023 have both seen higher funding totals than the same quarters in 2020, and Q3 and Q4 of 2022 have both seen higher funding than the same quarters in 2019 (pre-Covid).
The recent annual decrease in debt/equity funding is largely due to the recent rise in interest rates, making this type of funding more expensive.

July 31, 2023

US-NC-RLH Raleigh